| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/25/2012 | CN102327213A Triamcinolone acetonaide acetate nano eye drops and preparation method thereof |
| 01/25/2012 | CN102327212A Triamcinolone acetonaide acetate nano controlled-release formulation, preparation method thereof and artificial lens containing same |
| 01/25/2012 | CN102327211A Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 01/25/2012 | CN102327014A Bayberry pillow |
| 01/25/2012 | CN102327011A Health-care traditional Chinese medicinal pillow |
| 01/25/2012 | CN102091006B Tea extract facial cleanser and preparation method thereof |
| 01/25/2012 | CN102048959B Dendrobium candidum compound preparation capable of regulating function of human body in two-way manner and preparation method thereof |
| 01/25/2012 | CN102008515B Construction method of ganoderma spore powder polysaccharide fingerprint and standard fingerprint of ganoderma spore powder polysaccharide |
| 01/25/2012 | CN101912596B Medicament for treating allergic rhinitis and preparation method thereof |
| 01/25/2012 | CN101869552B Preparation method of chitin tablet |
| 01/25/2012 | CN101829189B Traditional Chinese medicine composition for treating allergic dermatitis |
| 01/25/2012 | CN101721677B Thymopentin oral microsphere preparation and preparation method thereof |
| 01/25/2012 | CN101703484B Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
| 01/25/2012 | CN101683519B Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof |
| 01/25/2012 | CN101590114B Medicament for treating multiple sclerosis and preparation method thereof |
| 01/25/2012 | CN101569656B Traditional Chinese medicine preparation and preparation method thereof |
| 01/25/2012 | CN101549046B Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
| 01/25/2012 | CN101361774B Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof |
| 01/25/2012 | CN101293931B Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof |
| 01/25/2012 | CN101085813B Soluble TNF acceptor mutant |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101211 Controlling moisture, elasticity of skin; using plant extracts; antiinflammatory agents; antiallergens |
| 01/24/2012 | US8101194 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | CA2522594C Mitotic kinesin inhibitor |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2496698C 5-h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 01/24/2012 | CA2494761C Oral pharmaceutical compositions comprising cyclosporin |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2492848C Isolation and identification of t cells |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2387542C Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/19/2012 | WO2012009663A2 New compounds for treating cancer and other diseases |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012006960A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006727A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | WO2012006718A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011112687A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011109551A3 Compounds that modulate intracellular calcium |
| 01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |
| 01/19/2012 | WO2011098762A3 Antibodies against cxcr4 |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016034 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof |
| 01/19/2012 | US20120016029 Antagonists of prostaglandin d2 receptors |
| 01/19/2012 | US20120016018 Composition for inducing multiple nuclear division of cells |
| 01/19/2012 | US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins |
| 01/19/2012 | US20120015982 Thiazolidinedione analogues |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015932 Pyrazole Derivatives Used as CCR4 Receptor Antagonists |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015912 Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015866 Prodrugs of Heteraromatic Compounds |
| 01/19/2012 | US20120015040 Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof |
| 01/19/2012 | US20120015000 Malaria vaccine of self-assembling polypeptide nanoparticles |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014996 Method of diagnosing bladder cancer |
| 01/19/2012 | US20120014995 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 01/19/2012 | US20120014993 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures |
| 01/19/2012 | US20120014991 Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/19/2012 | US20120014990 Vaccination methods |
| 01/19/2012 | US20120014989 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS |
| 01/19/2012 | US20120014988 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
| 01/19/2012 | US20120014987 Dna vaccine for alzheimer's disease |
| 01/19/2012 | US20120014986 Compositions and methods for reducing inflammation |
| 01/19/2012 | US20120014985 Vaccine Adjuvants |
| 01/19/2012 | US20120014983 recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 01/19/2012 | US20120014982 Methods and Compositions for Immunizing Against Chlamydia Infection |
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014980 Vaccines comprising tb10.4 |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014978 Compositions with reduced dimer formation |
| 01/19/2012 | US20120014975 Modified single domain antigen binding molecules and uses thereof |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014963 Probiotics, secretory iga and infection |
| 01/19/2012 | US20120014950 Antibodies That Specifically Bind to DR3 |
| 01/19/2012 | US20120014947 Methods and compositions to reduce liver damage associated with conditions or therapies that affect the immune system |
| 01/19/2012 | US20120014943 Optimized Anti-CD30 Antibodies |
| 01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |